175 related articles for article (PubMed ID: 26872102)
1. Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.
Sabra MM; Ghossein R; Tuttle RM
Thyroid; 2016 Apr; 26(4):518-24. PubMed ID: 26872102
[TBL] [Abstract][Full Text] [Related]
2. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH
Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
[TBL] [Abstract][Full Text] [Related]
4. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
6. Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
Sabra MM; Sherman EJ; Tuttle RM
Cancer; 2017 Aug; 123(15):2955-2964. PubMed ID: 28369717
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up.
Sohn SY; Kim HI; Kim YN; Kim TH; Kim SW; Chung JH
Clin Endocrinol (Oxf); 2018 Feb; 88(2):318-326. PubMed ID: 28972676
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.
Sabra MM; Dominguez JM; Grewal RK; Larson SM; Ghossein RA; Tuttle RM; Fagin JA
J Clin Endocrinol Metab; 2013 May; 98(5):E829-36. PubMed ID: 23533233
[TBL] [Abstract][Full Text] [Related]
9. Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung.
Kim M; Kim WG; Park S; Kwon H; Jeon MJ; Lee JJ; Ryu JS; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Jan; 27(1):49-58. PubMed ID: 27750021
[TBL] [Abstract][Full Text] [Related]
10. The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland.
Nixon IJ; Whitcher MM; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Thyroid; 2012 Sep; 22(9):884-9. PubMed ID: 22827579
[TBL] [Abstract][Full Text] [Related]
11. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.
Hirsch D; Levy S; Tsvetov G; Gorshtein A; Slutzky-Shraga I; Akirov A; Robenshtok E; Shimon I; Benbassat CA
Endocr Pract; 2017 Oct; 23(10):1193-1200. PubMed ID: 28704099
[TBL] [Abstract][Full Text] [Related]
12. Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.
Schvartz C; Bonnetain F; Dabakuyo S; Gauthier M; Cueff A; Fieffé S; Pochart JM; Cochet I; Crevisy E; Dalac A; Papathanassiou D; Toubeau M
J Clin Endocrinol Metab; 2012 May; 97(5):1526-35. PubMed ID: 22344193
[TBL] [Abstract][Full Text] [Related]
13. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases.
Bal CS; Garg A; Chopra S; Ballal S; Soundararajan R
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):745-51. PubMed ID: 25210762
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry-Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer.
Deandreis D; Rubino C; Tala H; Leboulleux S; Terroir M; Baudin E; Larson S; Fagin JA; Schlumberger M; Tuttle RM
J Nucl Med; 2017 May; 58(5):717-722. PubMed ID: 27738010
[TBL] [Abstract][Full Text] [Related]
16. Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid.
Podnos YD; Smith D; Wagman LD; Ellenhorn JD
Surgery; 2005 Dec; 138(6):1072-6; discussion 1076-7. PubMed ID: 16360393
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis.
Showalter TN; Siegel BA; Moley JF; Baranski TJ; Grigsby PW
Cancer Biother Radiopharm; 2008 Oct; 23(5):655-9. PubMed ID: 18976119
[TBL] [Abstract][Full Text] [Related]
18. TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma.
Penna GC; Pestana A; Cameselle JM; Momesso D; de Andrade FA; Vidal APA; Araujo Junior ML; Melo M; Fernandes PV; Corbo R; Vaisman M; Sobrinho-Simões M; Soares P; Vaisman F
Endocrine; 2018 Sep; 61(3):489-498. PubMed ID: 29948935
[TBL] [Abstract][Full Text] [Related]
19. Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.
Fatourechi V; Hay ID; Javedan H; Wiseman GA; Mullan BP; Gorman CA
J Clin Endocrinol Metab; 2002 Apr; 87(4):1521-6. PubMed ID: 11932275
[TBL] [Abstract][Full Text] [Related]
20. Prognosis and prognostic factors of differentiated thyroid carcinoma after the appearance of metastasis refractory to radioactive iodine therapy.
Ito Y; Miyauchi A; Ito M; Yabuta T; Masuoka H; Higashiyama T; Fukushima M; Kobayashi K; Kihara M; Miya A
Endocr J; 2014; 61(8):821-4. PubMed ID: 24871888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
